PNEUMOCYSTIS JIROVECII INFECTION
Clinical trials for PNEUMOCYSTIS JIROVECII INFECTION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECII INFECTION trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECII INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Which PCP treatment works best when the usual drug fails?
Disease control Not yet recruitingThis study looks at people with weakened immune systems who have a lung infection called PCP and cannot take the standard antibiotic. Researchers will compare different alternative treatments to see which one works best and has the fewest side effects. About 416 adults will take …
Matched conditions: PNEUMOCYSTIS JIROVECII INFECTION
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 26, 2026 10:44 UTC
-
Could shorter steroid courses be safer for severe pneumonia patients?
Disease control Not yet recruitingThis study looks at how long adults with severe Pneumocystis pneumonia (a serious lung infection) should take steroids. People who get better quickly (no longer need oxygen by day 10) will either stop steroids then or continue for 21 days. The goal is to see if stopping earlier r…
Matched conditions: PNEUMOCYSTIS JIROVECII INFECTION
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 19, 2026 12:00 UTC